Bylenta MLN 10mg/25mg/40mg Tablet
By Bylenta MLN
Rx
15 Tablet in a Strip

Composition
Cilnidipine(10mg) + Metoprolol Succinate(25mg) + Telmisartan(40mg)

Manufacturer - Lloyd Healthcare Pvt Ltd
702, Balaji Business Park, Andheri Kurla Road, Marol Naka, Andheri East, Gamdevi, Marol, Andheri East, Mumbai, Maharashtra 400059

Expires on or after
August, 2025

liver
When it comes to using Bylenta MLN 10mg/25mg/40mg Tablet, it is important to take special care if you have liver disease. Adjustments to the dosage of Cilmikaa TM tablet may be necessary in such cases, so it's crucial to consult your doctor before using it. It is advised not to use Bylenta MLN 10mg/25mg/40mg Tablet if you have severe liver disease. Since there is limited information available on the use of Cilmikaa 10 Tablet 10's in patients with liver issues, it is recommended to use it cautiously and only after consulting with your doctor.

kidney
Limited information is available on using Bylenta MLN 10mg/25mg/40mg Tablet in patients with kidney disease. Consult your doctor. Cilmikaa 10 Tablet may be safe, but inform your doctor if you have kidney disease.

alcohol
Avoid consuming alcohol while taking Bylenta MLN 10mg/25mg/40mg Tablet. Alcohol can worsen the side effects of the medication, such as dizziness and drowsiness, and may cause a sudden drop in blood pressure when standing.

driving
Bylenta MLN 10mg/25mg/40mg Tablet may reduce alertness, impact vision, and induce drowsiness or dizziness. If these effects arise, avoid driving. Limited studies suggest it may affect driving ability, consult your doctor.

pregnancy
Bylenta MLN 10mg/25mg/40mg Tablet is not safe to use during pregnancy as it poses risks to the baby. In rare life-threatening cases, a doctor may recommend it only if benefits exceed risks. Consult your doctor before use. No clinical data on Cilmikaa 10 Tablet 10's in pregnancy is available; consult your doctor if pregnant or planning.

breastfeeding
It is better to consult your doctor before using Bylenta MLN 10mg/25mg/40mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹205.5
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024